Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Freeflow Ventures is an early-stage venture capital firm founded in 2019 and based in Berkeley, California. The firm has invested in over 30 companies, focusing on deep tech solutions that leverage artificial intelligence and machine learning. Their portfolio includes startups in sectors such as healthcare, biotech, and climate.
Freeflow Ventures invests in early-stage companies across pre-seed, seed, Series A, and Series B funding rounds. Their investment strategy emphasizes deep tech solutions in human health and planetary health, targeting industries like biomanufacturing, drug discovery, medical devices, and carbon capture. The firm seeks to support science-driven founders who utilize advanced technologies to tackle significant challenges.
Notable portfolio companies include Iambic Therapeutics, a platform for small-molecule drug discovery using physics-informed AI; StrokeDx, which innovates stroke diagnosis with non-invasive imaging technology; Hydrosat, providing geospatial intelligence for food security via satellite imagery; and Captura, developing systems for large-scale carbon dioxide capture from ocean water.
Submit your pitch through their contact form at https://freeflow.io/contact/.
Yes, Freeflow Ventures often leads funding rounds, particularly in their focus areas of deep tech and health.
The firm is open to follow-on investments, especially for companies that align with their mission and demonstrate significant progress.
Specific fund size details are not disclosed, but the firm actively invests across multiple early-stage rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.